NYSE: BMY
Bristol Myers Squibb Co Stock

BMY Price
$60.13
Fair Value Price
N/A
Market Cap
$136.06B
52 Week Low
$46.40
52 Week High
$67.43
P/E
-214.75x
P/B
2.77x
P/S
3.82x
PEG
N/A
Dividend Yield
2.86%
Revenue
$34.86B
Earnings
-$563.00M
Gross Profit Margin
69.60%
Operating Margin
7.23%
Net Profit Margin
-1.60%
Debt to Equity
1.61
Operating Cash Flow
$13B
Beta
0.68
Next Earnings
Nov 5, 2020
Ex-Dividend
Oct 1, 2020
Next Dividend
Nov 2, 2020

Zen Score

High
Medium
Low
38
Industry average

Reasons for this score

BMY is good value based on its book value relative to its share price (2.77x), compared to the US market average (63.37x)
Valuation
BMY is good value based on its book value relative to its share price (2.77x), compared to the US Drug Manufacturers - General industry average (7.88x)
Valuation
BMY's Earnings (EBIT) of $2.52B can safely cover interest payments on company debt ($46.67B)
Financials

1 of 9

BMY News

Valuation

BMY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-214.75x
Industry
-10.98x
Market
46.79x

BMY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.77x
Industry
7.88x
Market
63.37x
BMY is good value based on its book value relative to its share price (2.77x), compared to the US market average (63.37x)
Valuation
BMY is good value based on its book value relative to its share price (2.77x), compared to the US Drug Manufacturers - General industry average (7.88x)
Valuation

BMY's financial health

Profit margin

Revenue
$10.8B
Net Income
-$775.0M
Profit Margin
-7.20%
BMY's Earnings (EBIT) of $2.52B can safely cover interest payments on company debt ($46.67B)
Financials
BMY's profit margin has decreased (-27.60%) in the last year from (26.00%) to (-1.60%)
Financials

Assets to liabilities

Assets
$129.3B
Liabilities
$79.3B
Debt to equity
0.94
BMY's short-term assets ($34.34B) exceed its short-term liabilities ($23.42B)
Financials
BMY's long-term liabilities ($55.50B) exceed its short-term assets ($34.34B)
Financials
BMY's debt has increased relative to shareholder equity (1.61), over the past 5 years ago (1.10)
Financials
BMY's debt to equity ratio (1.61) is considered high
Financials

Cash flow

Operating
$3.9B
Investing
$653.0M
Financing
-$1.1B
BMY's operating cash flow ($12.76B) is sufficient to service the company's debt ($46.67B)
Financials

Bristol Myers Squibb Stock FAQ

(NYSE: BMY) Bristol Myers Squibb trades on the NYSE under the ticker symbol BMY. Bristol Myers Squibb stock quotes can also be displayed as NYSE: BMY.
(NYSE: BMY) Bristol Myers Squibb stock price per share is $60.13 today (as of Oct 23, 2020).
(NYSE: BMY) Bristol Myers Squibb's 52-week high was $67.43, and its 52-week low was $46.40. It is currently -10.83% from its 52-week high and 29.59% from its 52-week low.
(NYSE: BMY) Bristol Myers Squibb's market cap is $136.06B, as of Oct 25, 2020.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bristol Myers Squibb's market cap is calculated by multiplying BMY's current stock price of $60.13 by BMY's total outstanding shares of 2,262,689,755.
(NYSE: BMY) Bristol Myers Squibb currently has 2,262,689,755 outstanding shares. With Bristol Myers Squibb stock trading at $60.13 per share, the total value of Bristol Myers Squibb stock (market capitalization) is $136.06B.

Bristol Myers Squibb stock was originally listed at a price of $47.32 in Dec 31, 1997. If you had invested in Bristol Myers Squibb stock at $47.32, your return over the last 22 years would have been 27.08%, for an annualized return of 1.10%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics